US Stock MarketDetailed Quotes
ADTX Aditxt
- 0.1861
- -0.0399-17.65%
Close Dec 20 16:00 ET
- 0.1900
- +0.0039+2.10%
Post 19:57 ET
2.65MMarket Cap0.00P/E (TTM)
0.2099High0.1850Low10.75MVolume0.1975Open0.2260Pre Close2.50MTurnover75.54%Turnover Ratio0.00P/E (Static)14.23MShares338.800052wk High0.56P/B2.65MFloat Cap0.185052wk Low--Dividend TTM14.23MShs Float766400.0000Historical High--Div YieldTTM11.02%Amplitude0.1850Historical Low0.2320Avg Price1Lot Size
About Aditxt Company
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Richmond, VA.
Company Profile
SymbolADTX
Company NameAditxt
Listing DateJun 30, 2020
Founded2017
CEOMr. Amro A. Albanna
MarketNASDAQ
Employees47
Fiscal Year Ends12-31
Address737 North Fifth Street,Suite 200
CityRichmond
ProvinceVirginia
CountryUnited States of America
Zip Code23219
Phone1-650-870-1200
Websitehttp://www.aditxt.com
Company Executives
- Name
- Position
- Salary
- Amro A. Albanna
- Chairman of the Board and Chief Executive Officer
- 519.23K
- Dr. Shahrokh Shabahang, D.D.S.,M.S.,PhD
- Director and Chief Innovation Officer
- 358.84K
- Corinne Pankovcin
- Chief Mergers and Acquisitions Officer
- 390.33K
- Rowena Albanna
- Chief Operating Officer
- --
- Thomas J. Farley
- Chief Financial Officer and Principal Accounting Officer
- 381.45K
- Sylvia Hermina
- Director
- --
- Charles Athle Nelson
- Independent Director
- --
- Dr. Jeffrey W. Runge, M.D.
- Independent Director
- 3.86K
- Brian Brady
- Independent Director
- 3.86K
Heat List
US
Overall
Symbol
Price
% Chg
No Data